What are the long term effects of vascepa on heart health?

How does Vascepa affect cardiovascular events over time?

Vascepa reduces the risk of major cardiovascular events in patients with elevated triglycerides and established cardiovascular disease or diabetes. Clinical data show reductions in heart attack, stroke, and cardiovascular death when added to statin therapy.

What happens to heart attack and stroke rates if treatment continues beyond four years?

Treatment extensions from the REDUCE-IT trial show that benefits persist past the original study period. Patients who remained on therapy saw continued separation of event curves, suggesting sustained protection rather than diminishing returns.

Can Vascepa help patients with only high triglycerides but no diagnosed heart disease?

Current evidence does not support routine use in primary prevention. The REDUCE-IT trial focused on secondary prevention and diabetes with risk factors. Ongoing studies are examining whether eradicating residual risk from high triglycerides alone justifies broader prescribing.

Why are companies challenging this patent?

Amarin filed suit against multiple generic manufacturers after they submitted Abbreviated New Drug Applications. The company claims generic versions infringe on its patents covering the stable pharmaceutical composition of icosapent ethyl. Litigation continues in federal courts, with some early rulings favoring the company.

When does Vascepa's patent expire?

The primary composition-of-matter patent expires in 2030. Composition patents covering stability and formulation methods extend protection until 2033. [1]

What side effects are patients asking about?

Patients report bleeding risk, atrial fibrillation, and occasional arthralgia. The manufacturer lists these als